ARNA Shares Outstanding History
Below is a table of the ARNA shares outstanding history going back to 6/19/2017:

Date ARNA Shares Outstanding

Also see: ARNA Market Cap History
ARNA Historical Shares Outstanding:
+18.27% CAGR
ARNA Historical Shares Outstanding: +18.27% CAGR

Mouse over chart for data details
6/19/2017 ...4/29/2021
Arena Pharmaceuticals is a biopharmaceutical company focused on delivering medicines with pharmacology and pharmacokinetics to patients globally. Co.'s clinical programs include: etrasimod (APD334), which Co. is evaluating in ulcerative colitis, and Crohn's disease, as well as a program for atopic dermatitis; olorinab (APD371), which is is being evaluated for a range of visceral pain conditions associated with gastrointestinal diseases and for treatment of abdominal pain associated with irritable bowel syndrome; APD418, which is being evaluated in a trial for acute heart failure; and Temanogrel, a compound in its cardiovascular therapeutic area. We show 18 historical shares outstanding datapoints in our coverage of ARNA's shares outstanding history.

Understanding the changing numbers of ARNA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ARNA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ARNA by allowing them to research ARNA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ARNA:
ARNA SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arena Pharmaceuticals (ARNA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ARQL Shares Outstanding History
ARRY Shares Outstanding History
ARWR Shares Outstanding History
ASMB Shares Outstanding History
ASNS Shares Outstanding History
ATEC Shares Outstanding History
ATHX Shares Outstanding History
ATNX Shares Outstanding History
ATOS Shares Outstanding History
ATRA Shares Outstanding History
More Healthcare companies »


ARNA Shares Outstanding History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.